João L. Carapinha

HIV Prevention Partnerships: Expanding Access to Lenacapavir for Global Impact

Escalating Public Spending: Semaglutide Off-Label Use Sparks €250 Million Fra...

Advancing Inclusive Healthcare Strategies Through Social Impact and Sustainab...

Advancing Access: Generic Dapagliflozin Approval Enhanced for Type 2 Diabetes...

Closing the East-West Divide: Addressing Healthcare Investment Disparities in...

Safeguarding Access: Navigating Pharmaceutical Cost Pressures in Portugal